首页 | 本学科首页   官方微博 | 高级检索  
     

姑息化疗EGFR-TKI治疗失败后晚期非小细胞肺癌临床疗效观察
引用本文:杨军礼,张秀春,袁霞妹,楼君,黄曙. 姑息化疗EGFR-TKI治疗失败后晚期非小细胞肺癌临床疗效观察[J]. 实用肿瘤杂志, 2011, 26(1): 55-58
作者姓名:杨军礼  张秀春  袁霞妹  楼君  黄曙
作者单位:金华广福医院肿瘤内和,浙江,金华,321000
摘    要:目的观察晚期非小细胞肺癌EGFR-TKI治疗失败后姑息化疗的疗效及不良反应。方法姑息化疗EGFR-TKI治疗失败的晚期非小细胞肺癌患者16例,其中10例采取联合化疗,6例采取单药化疗。结果 16例患者中PR 1例,SD 10例,疾病控制率为68.8%;联合化疗组中位生存期13月,1年生存率60.0%;单药化疗组中位生存期8月,1年生存率33.3%,两组比较差异无统计学意义(P〉0.05)。两组不良反应轻微,均可耐受。结论对于EGFR-TKI治疗失败而且体力状况较好的晚期NSCLC患者,可尝试采取姑息化疗。

关 键 词:癌,非小细胞肺  EGFR-TKI  药物疗法  姑息疗法

Clinical observation of palliative chemotherapy for 16 patients with advanced non-small cell lung cancer failed in treatment of EGFR-TKI
YANG Jun-li,ZHANG Xiu-chun,YUAN Xia-mei,et al. Clinical observation of palliative chemotherapy for 16 patients with advanced non-small cell lung cancer failed in treatment of EGFR-TKI[J]. Journal of Practical Oncology, 2011, 26(1): 55-58
Authors:YANG Jun-li  ZHANG Xiu-chun  YUAN Xia-mei  et al
Affiliation:YANG Jun-li,ZHANG Xiu-chun,YUAN Xia-mei,et al(Department of Oncology,Jinhua Guangfu Hospital,Jinhua,321000,China)
Abstract:Objective To observe the efficacy and toxicity of palliative chemotherapy for patients with advanced non-small cell lung cancer(NSCLC) failed in the treatment of EGFR-TKI.Methods Sixteen patients with advanced NSCLC failed in the treatment of EGFR-TKI were divided into two groups.Ten cases received combination chemotherapy and 6 cases were treated with single-agent chemotherapy.Results Among the 16 patients with advanced NSCLC failed in the treatment of EGFR-TKI,partial response(PR) accounted for 6.25%;stab...
Keywords:carcinoma  non-small cell lung  EGFR-TKI  drug therapy  palliative care  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号